Effects of Intervention With the Glucagon-like Peptide 1 (GLP-1) Analog Liraglutide Plus Metformin Versus Metformin Monotherapy in Overweight/Obese Women With Metabolic Defects and Recent History of Gestational Diabetes Mellitus (GDM)
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 20 Nov 2017
At a glance
- Drugs Liraglutide (Primary) ; Metformin
- Indications Gestational diabetes
- Focus Therapeutic Use
- 14 Nov 2017 Planned End Date changed from 1 Dec 2019 to 1 Jun 2019.
- 14 Nov 2017 Planned primary completion date changed from 1 Jun 2018 to 1 Mar 2019.
- 14 Nov 2017 Status changed from recruiting to active, no longer recruiting.